Zobrazeno 1 - 6
of 6
pro vyhledávání: '"P M, Kaiguri"'
Autor:
F A, Okoth, P M, Kaiguri, E, Mathenge, J, Tuei, S, Muchiri, N, Owino, G, Kamau, J, Kulundu, A, Njuguna, P M, Tukei, M, Yano, T, Naruse
Publikováno v:
East African medical journal. 76(9)
Kenya is a high hepatitis B virus (HBV) endemic zone. Prevention of HBV transmission by transfusing safe blood is necessary. Kits for screening hepatitis B surface antigen (HBsAg) are usually imported and are expensive. Hence it has been difficult to
Autor:
F A, Okoth, P M, Kaiguri, J, Tuei, E M, Mathenge, N O, Ragot, G, Kamau, J, Kulundu, V, Osidiana, A, Njuguna, P M, Tukei
Publikováno v:
East African medical journal. 75(11)
To determine the efficacy and safety of hepaccine B.Vaccination on first-come-first-served basis.Kenya Medical Research Institute (KEMRI) staff and families at Nairobi, Kenya.A total of 107 vaccinees aged 0-10 years and 10 years and above.Antibody to
Autor:
P M, Kaiguri, F A, Okoth, F, Lida, N, Matsumura, J, Tuei, E G, Mathenge, A, Kasomo, E, Ireri, G M, Kamati, V O, Osidiana, N R, Owino, J M, Kuiundu, A W, Njuguna, P M, Tukei, M, Yano, T, Fujino, H, Yatsuhashi, M, Koga, R, Hamada, T, Fukui, M, Nagatomo
Publikováno v:
African journal of health sciences. 3(2)
We undertook a study on selected samples from patients who had presented with viral hepatitis and conditions of the liver (liver cirrhosis, chronic hepatitis and hepatocellular carcinoma). Diagnosis, screening and confirmation for viral hepatitis was
Publikováno v:
East African medical journal. 71(4)
One hundred and seventy four high risk cases were vaccinated at Muranga district in Kenya. The plasma derived HB vaccine was used in 61 cases (group 1) and recombinant HB vaccine was used in 113 cases (group 2). Fifty five cases (90.2%) in group 1 an
Publikováno v:
East African medical journal. 68(7)
An HBV carrier rate of 3.0% in outpatients and 1.4% in school children, was found in a sero-epidemiological survey in Muranga District, Kenya. The prevalence of anti-Delta in HBV carriers was 42%. The prevalence of HBV carriers and HBV marker positiv
Publikováno v:
East African medical journal. 67(9)
Community based longitudinal epidemiological study of hepatitis B virus (HBV) was done in Maragua between June 1986 and November 1987. Hepatitis B surface antigen (HBsAg) carrier rate in the community was 3%. The high risk groups of HBV infection in